StockData
CapsoVision, Inc logo

CapsoVision, Inc (CV) stock

CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30686% above fair value
$6.31−0.51 (-7.48%)

Close on Nov 19, 2026Market cap $315.80MP/E –Yield –

CapsoVision gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

CapsoVision's gross profit for the twelve months ending Jun 30, 2026 was $7.07M, up 5.6% year over year. For fiscal 2025 it was $7.17M, up 12.5% from the year before.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.17M+12.5%
FY2024Dec 31, 2024$6.38M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.87M+3.3%
Q1 FY2026Mar 31, 2026$1.33M-11.0%
Q4 FY2025Dec 31, 2025$1.95M+12.7%
Q3 FY2025Sep 30, 2025$1.91M+15.5%
Q2 FY2025Jun 30, 2025$1.81M+13.8%
Q1 FY2025Mar 31, 2025$1.49M–
Q4 FY2024Dec 31, 2024$1.73M–
Q3 FY2024Sep 30, 2024$1.66M–
Q2 FY2024Jun 30, 2024$1.59M–

More CapsoVision figures

See a number that looks wrong?